Health Professional Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Professional Times.

Press releases published on September 28, 2026

6 hours ago

Tim Laros of ABC 360® Opens Pre-Orders October 6 After Last Production Run Sells Out Early

Indeterminate EIN Presswire

6 hours ago

One Water Systems Introduces Referral Program and Old System Buyback for Homeowners Upgrading Water Treatment

Indeterminate EIN Presswire

7 hours ago

How Conlight Continues to Outperform Other High-Quality Blood Detection Test Suppliers in Diagnostic Innovation

Indeterminate EIN Presswire

7 hours ago

Metaverse Lab-XR: Virtual Lab Builds Diagnostic and Teamwork Skills for Medical Technology Students

Indeterminate EIN Presswire

7 hours ago

NERDS ON SITE REPORTS RECORD $13.44 MILLION REVENUE AND 95% IMPROVEMENT IN OPERATING LOSS FOR FISCAL 2026

Indeterminate EIN Presswire

7 hours ago

Novel Endothelial Subtype Uncovered in Human Coronary Atherosclerosis

Indeterminate EIN Presswire

7 hours ago

Beyond the 'Happy Molecule': 5-HT as a Core Neurotransmitter of the Gut-Brain Axis

Indeterminate EIN Presswire

7 hours ago

Carboxymethyl-Lysine (CML): A Core AGEs Biomarker Decoding Glycation Stress and Chronic-Disease Mechanisms

Indeterminate EIN Presswire

9 hours ago

Protein Assay Platform Selection Guide: How to Choose Between ELISA, CBA, Luminex and MSD

Indeterminate EIN Presswire

11 hours ago

The Artificial Dermis Market Is Projected to Experience a Steady 9% CAGR Driven by Growing Industry Applications

Indeterminate EIN Presswire

an hour ago

4basebio and TriLink BioTechnologies Partner to Advance Leading Pharmaceutical Company’s Phase I Cell Therapy Program

Indeterminate GlobeNewswire

an hour ago

Pharmazz Completes Enrollment in 160-Patient Phase 4 Trial of Sovateltide in Acute Ischemic Stroke

Indeterminate GlobeNewswire

an hour ago

Arvinas Announces First Patient Dosed in Phase 1/2 Clinical Trial of ARV-6723, the Company’s First Immuno-Oncology Candidate

Indeterminate GlobeNewswire

an hour ago

Moleculin Announces Publication of Peer-Reviewed Cardiac Safety Analysis of Annamycin in Frontiers in Cardiovascular Medicine

Indeterminate GlobeNewswire

an hour ago

BrewDog Builds Momentum for Next Growth Chapter with Expanded Senior Leadership Team

Indeterminate GlobeNewswire

an hour ago

BlossomHill Therapeutics Presents Preclinical Data on Novel Pan-KRAS Inhibitor, BH-501284, at the AACR Conference on Pancreatic Cancer

Indeterminate GlobeNewswire

an hour ago

Psyence BioMed Announces Exclusive U.S. Ibogaine Licence for Texas Ibogaine Research Corporation

Indeterminate GlobeNewswire

an hour ago

Sagimet Biosciences to Host Virtual KOL Event, “Denifanstat Update: 52-Week Data from Phase 3 Open-Label Extension in China and Planned AURORA Phase 3 Clinical Trial in US” on September 30, 2026

Indeterminate GlobeNewswire

an hour ago

Tiziana Life Sciences Announces First Participants Dosed in ALS BANYAN Clinical Trial of Intranasal Foralumab

Indeterminate GlobeNewswire

an hour ago

Eton Pharmaceuticals Announces U.S. Commercial Availability of IMPAVIDO® (miltefosine) Capsules

Indeterminate GlobeNewswire